ATE295166T1 - Aktivatoren der kalium-kanäle - Google Patents

Aktivatoren der kalium-kanäle

Info

Publication number
ATE295166T1
ATE295166T1 AT99900312T AT99900312T ATE295166T1 AT E295166 T1 ATE295166 T1 AT E295166T1 AT 99900312 T AT99900312 T AT 99900312T AT 99900312 T AT99900312 T AT 99900312T AT E295166 T1 ATE295166 T1 AT E295166T1
Authority
AT
Austria
Prior art keywords
substituted
amino
aryl
pharmaceutical composition
alkyl
Prior art date
Application number
AT99900312T
Other languages
English (en)
Inventor
Mitsushi Tanaka
Masami Tsuda
Ayatsugu Nakamura
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE295166T1 publication Critical patent/ATE295166T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4162,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99900312T 1998-01-14 1999-01-13 Aktivatoren der kalium-kanäle ATE295166T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP561398 1998-01-14
JP5088898 1998-03-03
PCT/JP1999/000103 WO1999036068A1 (en) 1998-01-14 1999-01-13 Potassium channel activators

Publications (1)

Publication Number Publication Date
ATE295166T1 true ATE295166T1 (de) 2005-05-15

Family

ID=26339581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900312T ATE295166T1 (de) 1998-01-14 1999-01-13 Aktivatoren der kalium-kanäle

Country Status (10)

Country Link
US (1) US6353016B1 (de)
EP (1) EP1057485B1 (de)
KR (1) KR20010034114A (de)
CN (1) CN1162151C (de)
AT (1) ATE295166T1 (de)
AU (1) AU1890299A (de)
CA (1) CA2316853A1 (de)
DE (1) DE69925250T2 (de)
RU (1) RU2204390C2 (de)
WO (1) WO1999036068A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283040A4 (de) * 2000-03-21 2008-05-14 Nippon Shinyaku Co Ltd Orale heilmittelform für dauerverabreichung
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
TWI239952B (en) * 2001-03-14 2005-09-21 Nippon Shinyaku Co Ltd Stable crystals of pyrrole compound
WO2005023237A1 (en) * 2003-09-04 2005-03-17 Poseidon Pharmaceuticals A/S Erg channel openers for the treatment of cardiac arrhythmias
EP1773768B8 (de) * 2004-07-30 2018-12-26 Exelixis, Inc. Pyrrolderivate als pharmazeutische wirkstoffe
EP2297089B1 (de) * 2008-04-28 2013-07-31 Janssen Pharmaceutica, N.V. Benzocycloheptan- und benzoxepinderivate
GB201107176D0 (en) * 2011-04-28 2011-06-15 Cxr Biosciences Ltd Pyrrolnitrin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2113399T3 (es) * 1991-12-26 1998-05-01 Mitsubishi Chem Corp Derivados de beta-oxo-beta-bencenopropano-tio-amida.
FR2698873B1 (fr) * 1992-12-07 1995-02-24 Lipha Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
JP3439249B2 (ja) * 1993-11-18 2003-08-25 三和生薬株式会社 新規なピロール型化合物及び発毛・育毛促進剤
BR9608502A (pt) * 1995-06-07 1999-07-06 Nippon Shinyaku Co Ltd Derivado da pirrola e composição medicinal
EP0859771A4 (de) * 1995-10-31 2000-03-15 Merck & Co Inc Substituierte pyridylpyrrole, solche verbindungen enthaltende zubereitungen und verfahren zu deren nutzung
EP0912548A1 (de) * 1996-07-11 1999-05-06 Pfizer Inc. Pyridylpyrrol-derivate verwendbar als interleukin- und tnf- antagonisten
WO1999061016A1 (fr) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Inhibiteurs de cyclo-oxygenase-2

Also Published As

Publication number Publication date
EP1057485A4 (de) 2001-05-09
CN1288377A (zh) 2001-03-21
EP1057485A1 (de) 2000-12-06
DE69925250T2 (de) 2006-02-23
WO1999036068A1 (en) 1999-07-22
DE69925250D1 (de) 2005-06-16
CN1162151C (zh) 2004-08-18
AU1890299A (en) 1999-08-02
CA2316853A1 (en) 1999-07-22
US6353016B1 (en) 2002-03-05
RU2204390C2 (ru) 2003-05-20
KR20010034114A (ko) 2001-04-25
EP1057485B1 (de) 2005-05-11

Similar Documents

Publication Publication Date Title
BRPI0213243B8 (pt) composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
EP0976748A4 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы
FI950309A0 (fi) Proliiniamidijohdannaisia
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
BRPI9908319B8 (pt) composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo.
EA200200938A1 (ru) Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение
NZ332960A (en) tetrahydro-cyclopropan[c]benz[e]-indol-4-one and tetrahydro-cyclopropan[c]benzo[e]-indole derivatives and medicaments
NO20020725D0 (no) Celleadhesjonsinhibitorer
ATE343367T1 (de) Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
EP0751145A3 (de) HIV-Protease Inhibitoren
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
ES2128440T3 (es) Derivado de 4-alcoxi-2,6-di-t-butilfenol.
ATE295166T1 (de) Aktivatoren der kalium-kanäle
AU579872B2 (en) 2-amino-4-substituted oxazolines
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
AR019438A1 (es) Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion
EA200500028A1 (ru) Новые соединения 3-(4-оксо-4h-хромен-2-ил)-(1h)-хинолин-4-она, способ их получения и фармацевтические композиции, которые их содержат
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
EA200200379A3 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties